Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sarecycline in moderate to severe facial acne vulgaris
NCT02320149Phase 3Completed
- Sponsor
- Almirall
- Start
- Dec 2014
- Primary completion
- Feb 2017
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of sarecycline in acne vulgaris, sponsored by Almirall. Started Dec 2014; status: completed.
02
Drugs
sarecycline
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02320149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02320149.